Replenish & maintain vitamin D status in deficient older adults in RC

  • Research type

    Research Study

  • Full title

    Replenishing and maintaining vitamin D status in older adults in residential care facilities in NI

  • IRAS ID

    278254

  • Contact name

    Emeir McSorley

  • Contact email

    em.mcsorley@ulster.ac.uk

  • Sponsor organisation

    Ulster University

  • Duration of Study in the UK

    0 years, 6 months, 29 days

  • Research summary

    Vitamin-D deficiency is prevalent in older adults in NI, however the incidence among older adults within residential care facilities in this region is unknown. An observation study (IRAS id 237739 RECRef 18/NI/0114) is currently being carried out to provide data on the prevalence of vitamin-D deficiency among older adults within residential care facilities in NI. It is expected that 40% of the population will be deficient in vitamin D and will require immediate replenishment of vitamin D status.

    An intervention study will be conducted and participants identified as vitamin D deficient (25(OH)D) status <30nmol/L (cut-off currently used by the WHSCT will be re-contacted. The aim of this study is to investigate which dose and duration of vitamin D supplementation is required to replenish and maintain vitamin D status in older adults with vitamin D deficiency within residential care facilities. Participants will be randomly assigned to receive one of two supplementation regimes: 3200IU/day vitamin D3 or 20,000IU/week vitamin D3. Blood samples (no more than 20ml per appointment) will be taken at 4 different time points: week 0, week 2, week 4 and week 8. These two doses are routinely used in clinical practice for remedial supplementation of vitamin D and have been chosen based upon their availability from manufacturers of vitamin D supplements. Also, albeit these doses are currently routinely used to replenish vitamin D status little is known on how effective they are and how soon vitamin D status is optimised. Clinicians can only administer medication for the management of osteoporosis (e.g. Bisphosphonates) once vitamin D status is optimised; therefore we are taking measurements every two weeks to establish response to remedial supplementation. This project provides a unique opportunity to monitor the replenishment and maintenance of vitamin D status following remedial supplementation more regularly (at weeks 0,2,4,8) than would be done under standard NHS care. This is something that is currently ambiguous within the literature and clinical care.

  • REC name

    HSC REC A

  • REC reference

    20/NI/0031

  • Date of REC Opinion

    9 Mar 2020

  • REC opinion

    Further Information Favourable Opinion